| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |